← FDA DRUG APPROVALS

FDA ANDA · ANDA065462

CEFPODOXIME PROXETIL

Sponsor: SANDOZ

APPLICATION
ANDA065462
TYPE
ANDA
ORIGINAL APPROVAL
2008-05-28
LATEST ACTION
2014-02-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CEFPODOXIME PROXETILPrescription
CEFPODOXIME PROXETIL EQ 100MG BASE · TABLET · ORAL
CEFPODOXIME PROXETILPrescription
CEFPODOXIME PROXETIL EQ 200MG BASE · TABLET · ORAL

Approval history

2014-02-05Labeling · Supplement 5 · standard — Label ↗AP
2008-05-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →